WVU’s Clay Marsh to address congressional caucus on opioid epidemic

West Virginia University Health Sciences Vice President and Executive Dean Clay B. Marsh, MD, will address the Congressional Academic Medicine Caucus as part of a panel discussion on how medical schools and teaching hospitals are working to treat patients with opioid use disorders and ultimately stem the tide of overdoses in hard-hit and underserved areas of the country.

WVU Medicine and Rockefeller family announce new neuroscience institute

WVU Medicine and the Rockefeller family announced today that they have appointed neuroscientist Ali Rezai, M.D. to lead the comprehensive and integrated clinical and research programs in the neurosciences at West Virginia University and WVU Medicine. He will do so at the newly formed West Virginia University Rockefeller Neuroscience Institute.

WVU researcher receives $1.6 million to fight inflammation in neurodegenerative diseases

Inflammation is overwhelmingly beneficial, helping to fight illnesses caused by bacteria and viruses. However, most neurological diseases involve inflammation in the brain, which is thought to contribute to or exacerbate diseases. A West Virginia University researcher has been recently awarded $1.6 million to conduct research on how harmful inflammation can be targeted without disrupting normal immune function.

WVU biochemist goes online to X-ray life-sustaining crystals

Under conventional magnification, the crystals Aaron Robart grows in his West Virginia University lab may look like simple rock salt, but by bombarding them with X-rays, he and his research team can build computational models that reveal the molecules within.

WVU-led report shows smoking has not flamed out in all populations

The number one cause of preventable death is on the decline, but not for everyone. A new report led by a West Virginia University public health expert shows that despite a drop in cigarette smoking nationwide, minority groups are at higher risk for tobacco-related diseases than others.